Search Results 21-30 of 17289 for what is vedolizumab

  1. Vedolizumab Subcutaneous Long-Term Open-Label Extension Study - Mayo Clinic

    ... vedolizumab subcutaneous (vedolizumab SC) in participants with ulcerative colitis (UC) and Crohn's disease (CD). Participation eligibility. Participant ...

  2. Adalimumab-adaz (subcutaneous route) - Mayo Clinic

    Adalimumab-adaz injection is also used to treat moderate to severe active Crohn's disease. ... Vedolizumab; Warfarin; Yellow Fever Vaccine; Zoster Vaccine, Live ...

  3. Mayo Clinic Minute: What is inflammatory bowel disease?

    "Ulcerative colitis only impacts the colon and causes inflammation in the entire colon, while Crohn's disease can impact anywhere from the mouth to the anus," ...

  4. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

    ... Crohn's disease (CD) who achieved clinical response following administration of vedolizumab intravenous (vedolizumab IV) induction therapy. Participation ...

  5. Mesalamine (rectal route) - Mayo Clinic

    Mesalamineenema is used to treat active mild to moderate ulcerative colitis, proctitis or proctosigmoiditis (inflammation of the rectum and bowel). It works ...

  6. Adalimumab-bwwd (subcutaneous route) - Mayo Clinic

    Adalimumab-bwwd injection is also used to treat moderate to severe active Crohn's disease. ... Vedolizumab; Warfarin; Yellow Fever Vaccine; Zoster Vaccine, Live ...

  7. Balsalazide (oral route) - Mayo Clinic

    ... ulcerative colitis in patients 5 years of age and older. Balsalazide tablets are used to treat mild to moderately active ulcerative colitis in male patients ...

  8. Infliximab-abda (intravenous route) - Mayo Clinic

    Description. Infliximab-abda injection is used in adults to treat Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, ...

  9. Ulcerative Colitis Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the effectiveness and safety of vedolizumab intravenous (IV) treatment compared to adalimumab subcutaneous (SC) ...

  10. Mesalamine (oral route) - Mayo Clinic

    For the treatment of ulcerative colitis: For long-acting oral dosage form (delayed-release capsules):. Adults—800 milligrams (mg) 3 times a day.